NCT03155867
Completed
Not Applicable
Plasma Glucose and Insulin Response to Six Meal Replacements in Persons With Type 2 Diabetes Mellitus
Société des Produits Nestlé (SPN)1 site in 1 country13 target enrollmentApril 5, 2017
ConditionsDiabetes
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Diabetes
- Sponsor
- Société des Produits Nestlé (SPN)
- Enrollment
- 13
- Locations
- 1
- Primary Endpoint
- Area under the blood glucose curve (AUC 0-240)
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
This will be a randomized, cross-over design. Subjects will be randomized to one of six interventions on six separate study days, 1 week apart.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age 20-75 yrs
- •Type 2 diabetes controlled with diet or diet and oral agent, with the exception of sulfonylureas such as glimepiride (Amaryl), glipizide (Glucotrol/Glucotrol XL) and glyburide (DiaBeta, Micronase, Glynase Prestabs); meglitinides such as reaglinide (Prandin) and nateglinide (Starlix); and alpha-glucosidase inhibitors such as acarbose (Precose) and miglitol (Glyset)
- •Hemoglobin A1C less than 9.0%
- •Fasting blood glucose less than 180 mg
- •Hematocrit levels within normal limits
Exclusion Criteria
- •Abnormal thyroid function
- •Creatinine \>2.0 mg/dL
- •Potassium \<3.5 mEq/L
- •Gastrointestinal disease: ulcer, gastritis, diarrhea, gastroparesis, vomiting
- •Currently unstable diabetes or under treatment for cancer, heart disease, renal disease
- •Unable to give informed consent or follow instructions
- •Current insulin therapy or insulin therapy within the past month
- •Patient who are pregnant
- •Allergies to milk, soy or any component of the test product
- •Patient who in the Investigators assessment cannot be expected to comply with treatment
Outcomes
Primary Outcomes
Area under the blood glucose curve (AUC 0-240)
Time Frame: Baseline, 10, 20, 30, 60, 90, 120, 150, 180, 210 and 240 minutes
Secondary Outcomes
- Area under the insulin curves (AUC 0-240)(Baseline, 10, 20, 30, 60, 90, 120, 150, 180, 210 and 240 minutes)
- Insulinogenic index [Change in Ins30/Change in Glu30](Baseline, 10, 20, 30, 60, 90, 120, 150, 180, 210 and 240 minutes)
- AUC (0-30min) for insulin(Baseline, 10, 20, 30, 60, 90, 120, 150, 180, 210 and 240 minutes)
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Glycemic Response in Persons With Type 2 Diabetes MellitusDiabetes Mellitus, Type 2NCT04168541Société des Produits Nestlé (SPN)14
Completed
Not Applicable
Glycemic Response to Two Enteral Formulas in Persons With Type 2 Diabetes MellitusDiabetesNCT02898766Société des Produits Nestlé (SPN)12
Completed
Not Applicable
Glycemic Response to Three Oral Nutrition Supplements in Persons With Type 2 Diabetes MellitusDiabetesNCT02856516Société des Produits Nestlé (SPN)12
Completed
Not Applicable
Glycemic Response in Persons with Type 2 DiabetesDiabetes Mellitus, Type 2NCT04413357Société des Produits Nestlé (SPN)14
Completed
Not Applicable
Postprandial Glucose, Insulin Response to Meal Sequence Among Healthy UAE AdultsPostprandial HyperglycemiaNCT05878301University of Sharjah18